Terns Pharmaceuticals (TERN) Shares Outstanding (Diluted Average): 2021-2022

Historic Shares Outstanding (Diluted Average) for Terns Pharmaceuticals (TERN) over the last 2 years, with Dec 2022 value amounting to $36.0 million.

  • Terns Pharmaceuticals' Shares Outstanding (Diluted Average) rose 85.74% to $71.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $71.5 million, marking a year-over-year increase of 85.74%. This contributed to the annual value of $36.0 million for FY2022, which is 58.69% up from last year.
  • According to the latest figures from FY2022, Terns Pharmaceuticals' Shares Outstanding (Diluted Average) is $36.0 million, which was up 58.69% from $22.7 million recorded in FY2021.
  • In the past 5 years, Terns Pharmaceuticals' Shares Outstanding (Diluted Average) registered a high of $36.0 million during FY2022, and its lowest value of $22.7 million during FY2021.
  • Over the past 2 years, Terns Pharmaceuticals' median Shares Outstanding (Diluted Average) value was $29.4 million (recorded in 2021), while the average stood at $29.4 million.
  • Data for Terns Pharmaceuticals' Shares Outstanding (Diluted Average) shows a peak YoY surged of 58.69% (in 2022) over the last 5 years.
  • Terns Pharmaceuticals' Shares Outstanding (Diluted Average) (Yearly) stood at $22.7 million in 2021, then skyrocketed by 58.69% to $36.0 million in 2022.